Mersana Therapeutics, Inc. (MRSN)
NASDAQ: MRSN · Real-Time Price · USD
1.840
+0.020 (1.10%)
Nov 4, 2024, 4:00 PM EST - Market closed
Mersana Therapeutics Employees
Mersana Therapeutics had 123 employees as of December 31, 2023. The number of employees decreased by 105 or -46.05% compared to the previous year.
Employees
123
Change (1Y)
-105
Growth (1Y)
-46.05%
Revenue / Employee
$243,390
Profits / Employee
-$851,821
Market Cap
225.72M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
2seventy bio | 274 |
Utah Medical Products | 190 |
Nkarta | 150 |
Nektar Therapeutics | 137 |
Solid Biosciences | 88 |
XBiotech | 82 |
Eton Pharmaceuticals | 30 |
Trevi Therapeutics | 25 |
MRSN News
- 2 months ago - Mersana Therapeutics, Inc. (MRSN) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Mersana Therapeutics Provides Business Update and Announces Second Quarter 2024 Financial Results - GlobeNewsWire
- 3 months ago - Mersana Therapeutics to Host Second Quarter 2024 Conference Call on August 13, 2024 - GlobeNewsWire
- 5 months ago - Mersana Therapeutics to Present at Upcoming Investor Conferences - GlobeNewsWire
- 6 months ago - Mersana Therapeutics, Inc. (MRSN) Q1 2024 Earnings Call Transcript - Seeking Alpha
- 6 months ago - Mersana Therapeutics Provides Business Update and Announces First Quarter 2024 Financial Results - GlobeNewsWire
- 6 months ago - Mersana Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 6 months ago - Mersana Therapeutics to Host First Quarter 2024 Conference Call on May 9, 2024 - GlobeNewsWire